Stay updated on PV-10 with Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the PV-10 with Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the PV-10 with Pembrolizumab in Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Melanoma as a related topic and MedlinePlus Genetics; updated page revision to v3.4.2. Removed the funding-status notice and the previous Revision: v3.4.1.SummaryDifference0.6%

- Check21 days agoChange DetectedThe page now displays a government funding lapse notice about site operations and shows a revision update to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a glossary toggle; the page now shows Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed older items such as Melanoma, MedlinePlus Genetics, and the older Last Update/Revision entries (v3.3.4) from related topics and metadata.SummaryDifference0.4%

- Check35 days agoChange DetectedAdded Melanoma and MedlinePlus Genetics as related topics on the page. These changes provide metadata/links for discovery but do not modify the study details.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedRemoved the related topics entries for 'Melanoma' and 'MedlinePlus Genetics', reducing cross-links to related content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to PV-10 with Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PV-10 with Pembrolizumab in Melanoma Clinical Trial page.